Knop, Viola; Vermehren, Johannes; Herrmann, Eva et al.
Analysis of dynamic parameters predicting HBsAg seroclearance in a cohort of European untreated hepatitis B (HBV) infected patients: a prospective longitudinal study (ALBATROS Study)HEPATOLOGY. Bd. 60. 2014 S. 977A-977A
Hoffman, Arthur; Rey, Johannes Wilhelm; Mueller, Lena et al.
Analysis of interobserver variability for endomicroscopy of the gastrointestinal tractDIGESTIVE AND LIVER DISEASE. Bd. 46. H. 2. 2014 S. 140-145
Lee, Yun-Han; Seo, Daekwan; Choi, Kyung-Ju et al.
Antitumor Effects in Hepatocarcinoma of lsoform-Selective Inhibition of HDAC2CANCER RESEARCH. Bd. 74. H. 17. 2014 S. 4752-4761
Knapstein, Johanna; Galle, Peter R.; Zimmermann, Tim
Antiviral triple therapy with boceprevir in a chronic hepatitis C haemodialysis patient awaiting kidney re-transplantationDIGESTIVE AND LIVER DISEASE. Bd. 46. H. 1. 2014 S. 88-89
Sprinzl, Martin F.; Marquardt, Jens U.; Bartsch, Brigitte et al.
Array-based gene expression analysis of M1/M2-polarized macrophages during treatment with multi-kinase inhibitor SorafenibHEPATOLOGY. Bd. 60. 2014 S. 879A-880A
Beisel, Claudia; Weiler-Normann, Christina; Teufel, Andreas et al.
Association of autoimmune hepatitis and systemic lupus erythematodes: A case series and review of the literatureWORLD JOURNAL OF GASTROENTEROLOGY. Bd. 20. H. 35. 2014 S. 12662-12667
Wiltink, Joerg; Michal, Matthias; Wild, Philipp S. et al.
Associations between Depression and Diabetes in the Community: Do Symptom Dimensions Matter? Results from the Gutenberg Health StudyPLOS ONE. Bd. 9. H. 8. 2014
Schramm, Christoph; Lohse, Ansgar W.
Autoimmune hepatitis on the riseJOURNAL OF HEPATOLOGY. Bd. 60. H. 3. 2014 S. 478-479
Berger, Kristi L.; Triki, Ibtissem; Cartier, Mireille et al.
Baseline Hepatitis C Virus (HCV) NS3 Polymorphisms and Their Impact on Treatment Response in Clinical Studies of the HCV NS3 Protease Inhibitor FaldaprevirANTIMICROBIAL AGENTS AND CHEMOTHERAPY. Bd. 58. H. 2. 2014 S. 698-705
Gehrke, Nadine; Mann, Amrit; Alt, Yvonne et al.
Bcl-3 modulates hepatic glucose and lipid metabolism through insulin-signaling in a murine model of non-alcoholic fatty liver disease (NAFLD)HEPATOLOGY. Bd. 60. 2014 S. 739A-739A